dr. reddy's labs glp-1 receptor agonists weight management diabetes treatments With the launch of our oral semaglutide biosimilar, Obeda® tablets, we are broadening our GLP‑1 portfolio to offer more choice and flexibility for patients. Oral semaglutide, as a convenient and flexible option, Dr Reddy's Launches Oral Semaglutide

Do not reuse

Results In total, 204 cases of SSIBs associated with GLP-1RAs, including semaglutide, liraglutide, dulaglutide, exenatide, and albiglutide, were identified in the FAERS database

When you eat, your digestive system breaks carbohydrates into glucose, which then enters your bloodstream

A new deal may cut the cost of weight-loss drugs, but this UVA professor warns of potential long-term risks.

Focused on metabolic wellness over time

A new Phase 2 trial at Johns Hopkins testing the GLP-1 drug pegsebrenatide in progressive MS may finally explain why adults on diabetes medications for a decade show measurably slower brain shrinkage